{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:19:11Z","timestamp":1788967151582,"version":"build-2803163510"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background and Objectives:<\/jats:title>\n            <jats:p>This study aims to review how the introduction of propranolol as the primary treatment option for children with infantile hemangiomas (IHs) has affected the use of other treatment options at our institution and to determine the indications for surgical treatment of children with IHs in the propranolol era.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>The authors conducted a single-center, noncompeting, historical\/retrospective cohort study to review all cases referred to the institution for IH evaluation from 2005 to 2020. The authors analyzed the complete charts of patients who received surgery from 2011 to 2020 and evaluated the reasons for each surgical intervention. Detailed descriptive statistics are provided. Logistic regression analysis and Pearson\u2019s <jats:italic toggle=\"yes\">\u03c7<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>-test were applied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>During the study period, 592 children received treatment. From 2011, oral propranolol (<jats:italic toggle=\"yes\">n<\/jats:italic>=268; 74%) and surgery (<jats:italic toggle=\"yes\">n<\/jats:italic>=95; 26%) were the only treatments of choice for complicated IH cases. A significant decrease in the frequency of surgical treatment was observed (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.01). The authors identified four main indications for surgical treatment: (1) patients with ulceration and IH size appropriate for surgical resection (15%); (2) patients whose parents preferred surgical treatment (19%); (3) patients who presented late and underwent surgery before the age of three (29%); and (4) patients with sequelae after IH involution and excision after the third year of life (37%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Despite the significant decrease in the need for surgical treatment of children with IHs since the introduction of propranolol, there are still several clear indications for treating IH cases where surgery plays a crucial role.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000000324","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T05:03:31Z","timestamp":1679979811000},"page":"829-840","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Indications for surgical resection of complicated infantile hemangiomas in the \u03b2-blocker\u2019s era: a single-institution experience from a retrospective cohort study"],"prefix":"10.1097","volume":"109","author":[{"given":"Besiana P.","family":"Beqo","sequence":"first","affiliation":[{"name":"Department of Paediatric and Adolescent Surgery"},{"name":"Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3868-9136","authenticated-orcid":false,"given":"Paolo","family":"Gasparella","sequence":"additional","affiliation":[{"name":"Department of Paediatric and Adolescent Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9754-3794","authenticated-orcid":false,"given":"Christina","family":"Flucher","sequence":"additional","affiliation":[{"name":"Department of Paediatric and Adolescent Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Spendel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Plastic, Aesthetic and Reconstructive Surgery, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-9497","authenticated-orcid":false,"given":"Franz","family":"Quehenberger","sequence":"additional","affiliation":[{"name":"Institute for Medical Informatics, Statistics, and Documentation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-8100","authenticated-orcid":false,"given":"Emir Q.","family":"Haxhija","sequence":"additional","affiliation":[{"name":"Department of Paediatric and Adolescent Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4]]},"reference":[{"key":"R1-20250824","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpeds.2006.12.003","article-title":"Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics","volume":"150","author":"Haggstrom","year":"2007","journal-title":"J Pediatr"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/bjd.12804","article-title":"Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies","volume":"170","author":"Munden","year":"2014","journal-title":"Br J Dermatol"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1542\/peds.2014-3673","article-title":"Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies","volume":"136","author":"Wassef","year":"2015","journal-title":"Pediatrics"},{"key":"R4-20250824"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jamadermatol.2016.2905","article-title":"Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy","volume":"152","author":"Baselga","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1684\/ejd.2021.4172","article-title":"Sequelae following infantile haemangiomas treated with propranolol","volume":"31","author":"Baselga","year":"2021","journal-title":"Eur J Dermatol"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1055\/s-2008-1038772","article-title":"H\u00e4mangiomtherapie im Kindesalter: medikament\u00f6se Therapiem\u00f6glichkeiten und ihre Grenzen","volume":"41","author":"Haxhija","year":"2009","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile hemangioma: report of a consensus conference","volume":"131","author":"Drolet","year":"2013","journal-title":"Pediatrics"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N Engl J Med"},{"key":"R10-20250824","first-page":"CD006545","article-title":"Interventions for infantile haemangiomas of the skin","volume":"2018","author":"Novoa","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20250824","first-page":"000348942210897","article-title":"Should propranolol remain the Gold Standard for Treatment of Infantile Hemangioma? A systematic review and meta-analysis of propranolol versus atenolol","volume":"132","author":"Chen","year":"2022","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"e20151754","DOI":"10.1542\/peds.2015-1754","article-title":"Rebound growth of infantile hemangiomas after propranolol therapy","volume":"137","author":"Shah","year":"2016","journal-title":"Pediatrics"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"e14936","DOI":"10.1111\/dth.14936","article-title":"Propranolol for infantile hemangioma: evaluating efficacy and predictors of response and rebound growth","volume":"34","author":"Pam","year":"2021","journal-title":"Dermatol Ther"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/lsm.22455","article-title":"Laser treatment of infantile hemangioma: a systematic review","volume":"48","author":"Chinnadurai","year":"2016","journal-title":"Lasers Surg Med"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijsu.2019.11.002","article-title":"STROCSS 2019 Guideline: strengthening the reporting of cohort studies in surgery","volume":"72","author":"Agha","year":"2019","journal-title":"Int J Surg"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/archdischild-2011-300851","article-title":"Management of difficult infantile haemangiomas","volume":"97","author":"Maguiness","year":"2012","journal-title":"Arch Dis Child"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PRS.0000000000007699","article-title":"Propranolol therapy in infantile hemangioma: it is not just about the beta","volume":"147","author":"Lee","year":"2021","journal-title":"Plast Reconstr Surg"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/j.tvir.2013.01.006","article-title":"The role of surgery in the management of congenital vascular anomalies","volume":"16","author":"Waner","year":"2013","journal-title":"Tech Vasc Interv Radiol"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jpeds.2007.04.055","article-title":"Multicenter prospective study of ulcerated hemangiomas","volume":"151","author":"Chamlin","year":"2007","journal-title":"J Pediatr"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/SCS.0000000000001561","article-title":"Surgical management of scalp infantile hemangiomas","volume":"26","author":"Cho","year":"2015","journal-title":"J Craniofac Surg"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamapediatrics.2021.4565","article-title":"Noninferiority and safety of nadolol vs propranolol in infants with infantile hemangioma","volume":"176","author":"Pope","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/jamaoto.2021.0454","article-title":"Efficacy and safety of propranolol vs atenolol in infants with problematic infantile hemangiomas","volume":"147","author":"Ji","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1064-7406(23)00483-2","article-title":"Psychosocial impact of vascular birthmarks","volume":"9","author":"Lande","year":"2001","journal-title":"Facial Plast Surg Clin North Am"},{"key":"R24-20250824","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/PRS.0b013e31825dc129","article-title":"Infantile hemangioma","volume":"130","author":"Couto","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"R25-20250824","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/PHMT.S115528","article-title":"Current perspectives on the optimal management of infantile hemangioma","volume":"8","author":"Grzesik","year":"2017","journal-title":"Pediatr Health Med Ther"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1097\/00006534-200204150-00009","article-title":"Circular excision of hemangioma and purse-string closure: the smallest possible scar","volume":"109","author":"Mulliken","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00431-018-3290-z","article-title":"Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid","volume":"178","author":"L\u00f3pez-Guti\u00e9rrez","year":"2019","journal-title":"Eur J Pediatr"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jpedsurg.2018.08.001","article-title":"Surgical resection of infantile hemangiomas following medical treatment with propranolol versus corticosteroids","volume":"54","author":"Polites","year":"2019","journal-title":"J Pediatr Surg"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jamafacial.2017.0197","article-title":"Modern management of nasal hemangiomas","volume":"19","author":"Keller","year":"2017","journal-title":"JAMA Fac Plast Surg"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/IOP.0000000000001466","article-title":"Surgical intervention of periocular infantile hemangiomas in the era of \u03b2-blockers","volume":"36","author":"Men","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R31-20250824","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/eye.2011.164","article-title":"The use of propranolol in the management of periocular capillary haemangioma \u2013 a systematic review","volume":"25","author":"Spiteri Cornish","year":"2011","journal-title":"Eye"},{"key":"R32-20250824","first-page":"161","article-title":"Treatment of Cutaneous Hemangiomas In: Mulliken JB, Burrows PE, Fishman SJ (eds) Mulliken and Young\u2019s Vascular Anomalies: Hemangiomas and Malformations, 2nd ed Oxford University Press, New York","author":"Mulliken","year":"2013"},{"key":"R33-20250824","doi-asserted-by":"crossref","first-page":"8751","DOI":"10.4081\/dr.2021.8751","article-title":"Nd:YAG laser in association with pulsed dye laser for the treatment of PHACES syndrome","volume":"13","author":"Negosanti","year":"2021","journal-title":"Dermatol Rep"},{"key":"R34-20250824","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pde.15132","article-title":"Multicenter retrospective review of pulsed dye laser in nonulcerated infantile hemangioma","volume":"40","author":"Shah","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"R35-20250824","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jamadermatol.2021.0469","article-title":"Clinical features, prognostic factors, and treatment interventions for ulceration in patients with infantile hemangioma","volume":"157","author":"Fern\u00e1ndez Faith","year":"2021","journal-title":"JAMA Dermatol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:04:18Z","timestamp":1756062258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000000324","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"2022-12-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}